Documente Academic
Documente Profesional
Documente Cultură
Day 2015
Discover
more
Safe harbor
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’,
‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such
statements may be subject to risks and uncertainties that could cause the actual results to differ materially from
these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange
Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to
update forward-looking statements to reflect actual results, changed assumptions or other factors. This document
does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to
purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or
be relied on in connection with, any contract there for.
Our claims today
3
Continuing grower demand
for innovation
Yield
~$300bn
Biotic stress
– Weeds, insects, disease
~$600bn
– Resistance management
– Regulatory changes
Abiotic stress
– Climate change
– Constrained natural resources
– Change in input factors
Major pest shifts
~$900bn
Estimated total
economic value
Source: Syngenta estimates
4
Biotic stress and resistance
management
2014 estimated area Glyphosate resistance Global lepidoptera Insect resistance
affected by glyphosate increasing (chewing pest) market in Brazil
resistance
Up 20% year on year
to ~1/3 of total US 21 >$2bn – Bt resistance results in
tripling of lep control market
crop area resistant weeds market value – Viptera the only trait to
globally control Fall armyworm
Mha $m
58%
40
35
78
30
25 US farmers Sucking
20
15
affected in 2014 88
Chewing
122
10
5 33
0 Pluesia Helicoverpa
2013 2014
Brazil Argentina USA Spodoptera Other
5
Regulatory change: Syngenta capability
creates competitive advantage
Time and cost of innovation increasing Some key products no longer available to growers
– Additional study requirements Example: neonicotinoid seed treatment
– Protracted regulatory approval timelines
– Application of cut-off criteria
4:1
EU product withdrawals
outpacing new product
introductions
Cabbage stem flea beetle damage in oilseed rape in UK and Germany due to
suspension of neonicotinoid seed treatments
6
Yield improvement remains
an imperative
3.0% 6
3.0
Potential area
Total planted area for agricultural
2.0% 4 ~1.6 billion ha expansion
0.3 0.14
1.0% 2
1.2
0.3
0.0% 0
1970 1980 1990 2000 2010 Agricultural Permanent Permanent Major 0.3
Undefined
land meadows crops crops
Source: USDA (corn, soybean, rice, wheat), FAO Sources: FAO, World Bank, WWF
Syngenta analysis
7
Innovation lifecycle
Chemistry Revenue
Breeding GM Traits
Time
Cost
¹Active ingredient ²Product Life Cycle Management ³Average time in market is 3.5 years. * In next 12 months
50% don’t make it past 2 years – those
8 that do succeed last for many years.
Evolution of R&D spend by capability
1200
1000
CAGR 2001-2014
800
R&D Breeding
600
+5% +7%
400
GM Traits Chemistry
200
+8% +3% 0
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
% of sales 11.4% 11.2% 11.1% 11.1% 10.1% 10.5% 9.6% 8.9% 9.3% 9.4% 9.0% 8.9% 9.4% 9.4%
9
Syngenta R&D is the most
productive in the industry
Cumulated Cumulated R&D Sales/R&D
Sales $bn expenses $bn
2005-2014 2005–2014
– Period of investment in
51 4.8 10.5 Seeds platform
54 7.0 7.7
18% 18%
9% 9%
~600 7% 7%
* Launch defined as new Syngenta products (incl. formulations) marketed in specific countries Source: Phillips McDougall. Excluding professional products
11
Seeds: leading innovator
in trait technology
Corn trait revenue and royalty
income – cash basis
$m Traits Complete independent corn
1'000
2.5X trait platform
900
800
700 Comprehensive insect control
600 including Refuge In a Bag
500
400
MIR604: Pioneer enabled for
300 Access to market dual CRW control in USA
200
100 Access independent seed
- companies MIR162 licensed to Monsanto,
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
DuPont Pioneer, Dow: most
SYT Brands GLG licensees Direct licensees
Direct licensing to efficacious broad lep trait,
other majors
leading in Fall armyworm
Revenue stream to double in next 5 years following control in Brazil
China approval of MIR162 Branded business enablement
12
Crop Protection:
R&D productivity increasing
13
Rate of innovation accelerating
14
Innovation overview
Fungicides
Seguris Elatus Orondis Lead 3
Adepidyn
Insecticides
Lead 4 Lead 1
>$500m
Herbicides
Lead 2
Acuron
>$200m
Seedcare
Lead 5 Lead 7 >$100m
Vibrance Fortenza Clariva Lead 6
Peak sales
Year of launch 2012 2017 2022
potential
15
ADEPIDYNTM:
the next SDHI blockbuster
1. Sales by Region 2. Sales by Crop at peak – Time to peak sales often
Peak sales 3-5 years
$m
>$750 m – Chemistry design ensures
750 Vegetables Cereals
full registrability across
500 regions
Specialty >$750m
Corn
250 – Focus on Fusarium: broad
DFC crop applicability
-0 Soybean
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– Low cost to manufacture
North America Latin America EAME APAC
with COGS optimization
5 years from launch
3. Economies of scale in COGS 4. Free cash flow contribution – Free cash flow break even
AI Volume AI COGS $m 3 years from registration
‘000 kg $/kg 300
200
2'000 NPV @ 8%
100
~$1.2 bn
1'000
0
0 -100
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
16
Track record of delivering GM traits
– Rich early GM pipeline – Enhanced trait development – Leadership in above and below
with no route to market capabilities: successful launches ground insect control
of proprietary traits – Multiple modes of action to
manage insect resistance
17
Rich early pipeline and strong
biotechnology platform
Next CRW (corn rootworm)
– Attractive market driven by
resistance to existing MoAs
Relative probability
Next CRW
Next broad lep Replacement Traits
– Driven by resistance (Brazil, Southern US) for Insect Control
Water optimization 5x in late research – Several leads for manipulation of ABA pathway
6x with late research potential* – Multiple drought tolerance genes
Yield 2x with late research potential* – Members of gene families associated with increases in seed
number and grain weight
* In next 12 months
19
Hybrid wheat: game-changing non-GM technology
with peak sales potential >$3bn
Wheat area opportunity (in Mha) Hybrid wheat launch plan Strongest germplasm in
$bn the industry, leading
expertise
3
US
France,
US
India Canada
UK, Poland,
Germany Germany
CIS Technical proof of
concept achieved in 2014
2
Yield performance of
1 hybrids
20
Leverage in R&D: platforms enable flexible
use of expertise and resources
1. 2. 3.
Portfolio Product safety & Biological
platforms regulatory assessment
Combine CP and Seeds Early decision making Site consolidation:
Biological assessment sites
portfolio teams to reduce late development ~$40m cost saving 100%
20% reduction in employees attrition
Genotyping: 90%
21
Leveraging technology in genetics,
chemistry and computational science
Using our deep understanding of mode Existing chemistry New design
of action to drive innovation
Genetics + +
– We actively monitor for the first Fails in the resistant weed Activity against target restored
signs of evolution of herbicide
resistance in weeds
– We understand in detail how the
shape of the target has
changed in the resistant plant
Chemistry
– Making the herbicide fit again
– Resistance breaking chemistry
by design
Computational science
22
Leveraging our breadth and global
crop presence
23
Our claims today
24
New crop protection pipeline
Peak sales >$3.6bn
New blockbusters in large markets
Product Indication Crops Status Launch year Peak sales
ADEPIDYN™/pydiflumetofen Fungicide Cereals, corn, soybean, specialty vegetables Stage 3 2016 >$750m
26
Discover
more
at the Syngenta R&D Day
Bringing winning
innovation into the
hands of growers